Citation Impact

Citing Papers

Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
Novel radiolabeled antibody conjugates
2007
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer
1997 Standout
Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy
1994
Molecular imaging in drug development
2008 Standout
Immunospecific NMR contrast agents
1986
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Metal–organic framework composites
2014 Standout
Evaluation of Cytokeratin 7 as an accurate intracellular marker with which to assess the purity of human placental villous trophoblast cells by flow cytometry
2004 StandoutNobel
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody
2005
Evaluation of a new DTPA-derivative chelator: Comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts
1993
Conjugation of phenyl isothiocyanate derivatives of carborane to antitumor antibody and in vivo localization of conjugates in nude mice
1991
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
1988 StandoutNobel
New radiopharmaceuticals and new applications in medicine
1993
Imaging in the era of molecular oncology
2008 StandoutNature
New approaches to antibody therapy
2000
A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma
1989
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Expression of an antibody Fv fragment in myeloma cells
1988 StandoutNobel
Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin
1990
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer
1998
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
1990 Standout
Diagnosis of gastric cancers with fluorescein‐labeled monoclonal antibodies to carcinoembryonic antigen
1989
Chicken antibodies: a tool to avoid interference by complement activation in ELISA
1992 StandoutNobel
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Use of Carcinoembryonic Antigen Radioimmunodetection and Computed Tomography for Predicting the Resectability of Recurrent Colorectal Cancer
1997
Characterization of a hormone-producing ovarian carcinoma cell line
1989
Site-specific Conjugation on Serine → Cysteine Variant Monoclonal Antibodies
2000
Calmodulin as a Versatile Tag for Antibody Fragments
1995 StandoutNobel
Carboranyl peptide-antibody conjugates for neutron-capture therapy: preparation, characterization, and in vivo evaluation
1992
Site-specific99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain
2004
Does sports activity enhance the risk of sudden death in adolescents and young adults?
2003 Standout
Linkage of boronated polylysine to glycoside moieties of polyclonal antibody; boronated antibodies as potential delivery agents for neutron capture therapy 1 1Abbreviations: BNCT, Boron neutron capture therapy; BPL, Boronated poly-DL-lysine; BSA, Bovine serum albumin; DMBA, p-Dimethylaminobenzaldehyde; DMF, Dimethylformamide; DMSO, Dimethyl sulfoxide; DTT, Dithiothreitol; FTSC, Fluorescein thiosemicarbazide; HRP, Horseradish peroxidase; IgG, Immunoglobulin-G; IRMA, Immunoradiometric assay; LET, Linear energy transfer; MB-hydrazide, m-Maleimidobenzoyl hydrazide; MW, Molecular weight; PBS, Phosphate buffered saline; PL, Poly-DL-lysine; SDS-PAGE, Sodium n-Dodecyl Sulfate Polyacrylamide Gel Electrophoresis; SPDP, N-Succinimidyl-3-(2 pyridyldithio) propionate; Sulfo-MBS, m-Maleimidobenzoyl-N-hydroxysulfosuccinimide ester; TRIZMA®, Tris (hydroxymethyl) aminomethane; TSH, Thyroid stimulating hormone.
2002
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Chicken Antibodies: Taking Advantage of Evolution—A Review
1993 StandoutNobel
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Oncofetal reprogramming in tumour development and progression
2022
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
2008 Standout
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
2006 Standout
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Review of clinical radioimmunotherapy
2006
Novel carboranyl amino acids and peptides: reagents for antibody modification and subsequent neutron-capture studies
1991
Immobilized chicken antibodies improve the detection of serum antigens with surface plasmon resonance (SPR)
1998 StandoutNobel
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents
1994 StandoutNobel
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Challenges and Opportunities for the Application of Boron Clusters in Drug Design
2016
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Molecular recognition in antibodies and its application
1991
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
1983 Standout
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Applications of Radiolabeled Boron Clusters to the Diagnosis and Treatment of Cancer
1999
Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model
1991
Tumor-associated antigen in patients with carcinoma of the colon
1972
Heterophilic antibodies: a problem for all immunoassays.
1988
Precision Molecular Grafting:  Exchanging Surrogate Stoppers in [2]Rotaxanes
1999 StandoutNobel
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Overview of transition metal and lanthanide complexes as diagnostic tools
1999
Maximization and self-control
1981 StandoutNobel
Design by Directed Evolution
1998 StandoutNobel
The psychology and economics of demand.
1978
Synthesis of Boron‐Rich Lysine Dendrimers as Protein Labels in Electron Microscopy
1996
The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer
1993 Standout
The effect of particle design on cellular internalization pathways
2008 Standout
Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.
1986
Induced Differentiation of Avian Myeloblastosis Virus-Transformed Myeloblasts: Phenotypic Alteration Without Altered Expression of the Viral Oncogene
1984 StandoutNobel
Immunolocalization of neuroblastoma using radiolabeled monoclonal antibody UJ13A
1984
Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma
2000
Neutron-capture therapy of human cancer: in vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in the GW-39 tumor model system.
1984
Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.
1986
Dendrimers—Branching out from curiosities into new technologies
1998 StandoutNobel
Dysplasia in Inflammatory Bowel Disease
1980
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
1978 Standout
About Dendrimers:  Structure, Physical Properties, and Applications
1999 Standout
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
1991
Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
1999
Induced differentiation of avian myeloblastosis virus-transformed myeloblasts: phenotypic alteration without altered expression of the viral oncogene.
1984 StandoutNobel
Mammary Tumor Viruses
1979
TARGETED CONTRAST AGENTS IN MR IMAGING
1996
The Chemistry of Neutron Capture Therapy
1998 Standout
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
Endothelial Protein C Receptor-Assisted Transport of Activated Protein C across the Mouse Blood—Brain Barrier
2008
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
2000
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Molecular Dynamics of Ion−Chelate Complexes Attached to Dendrimers
1996 StandoutNobel
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
2019 StandoutNobel
Boron neutron capture therapy for cancer. Realities and prospects
1992
Multiple biochemical markers in patients with gynecologic malignancies
1980
The chemistry of boron analogues of biomolecules
1994
Therapeutic implications of patterns of recurrence in cancer of the uterine cervix
1979
Teratocarcinomas and Other Neoplasms as Developmental Defects in Gene Expression
1981
The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
2005
Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations.
1986
Surface molecular recognition
2001 StandoutNobel
Labelled compounds of interest as antitumour agents. Part 41. Deuteration and tritiation of a nitroimidazole‐carborane designed for BNCT
1994
Triphenylphosphonium-Stoppered [2]Rotaxanes
1999 StandoutNobel
Keratin proteins and carcinoembryonic antigen in lung carcinoma: An immunoperoxidase study of fifty-four cases, with ultrastructural correlations
1983
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003

Works of Sidney Bennett being referenced

Neutron-capture therapy of human cancer: in vitro results on the preparation of boron-labeled antibodies to carcinoembryonic antigen.
1982
Radioimmunodetection of cancer with radiolabeled antibodies to alpha-fetoprotein.
1980
Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen.
1980
Radiolabeling of affinity-purified goat anti-carcinoembryonic antigen immunoglobulin G with technetium-99m.
1980
Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning
1978
Immunologic Tests for the Detection of Gastrointestinal Cancers
1972
Adenocarcinoma of the small intestine arising in crohn's disease: Demonstration of a tumor‐associated antigen in invasive and intraepithelial components
1975
Elution of Tumor-Directed Antibody From Kidneys of Mammary Tumor-Bearing Mice2
1977
Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen.
1980
Improved protein labeling by stannous tartrate reduction of pertechnetate.
1980
Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms
1983
Carcinoembryonic antigen: immunohistologic identification in invasive and intraepithelial carcinomas of the lung.
1977
Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen.
1980
Price-quantity relationships and price elasticity under in-store experimentation
1974
Carcinoembryonic antigen in human ovarian neoplasms.
1975
Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies
1972
Rankless by CCL
2026